Champions Oncology Inc

NASDAQ:CSBR  
7.62
+0.09 (+1.20%)
Earnings Announcements

Champions Biotechnology Q1 Oncology Services Revenue $13.7 Million Versus $11.3 Million

Published: 09/08/2022 20:09 GMT
Champions Oncology Inc (CSBR) - Q1 Oncology Services Revenue $13.7 Million Versus $11.3 Million.
Champions Biotechnology Inc - Qtrly Loss per Share $0.02.
Further Company Coverage: .
((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $13.79 Million
Adjusted EPS is expected to be $0.01

Next Quarter Revenue Guidance is expected to be $15.32 Million
Next Quarter EPS Guidance is expected to be $0.06

More details on our Analysts Page.